一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Cancer Cell International >>article
Cancer Cell International

Cancer Cell International

IF: 5.3
Download PDF

FPR3 orchestrates macrophage polarization in breast cancer: multi-omics dissection of prognostic relevance and therapeutic targeting

Published:18 August 2025 DOI: 10.1186/s12935-025-03942-4 PMID: 40826412
Ying Chen,?Xin Tang,?Liran Zhu,?Yi Wang,?Gaopeng Li,?Wulin Yang

Abstract

Background: The N-formyl peptide receptor family (FPRs) is implicated in the progression of diverse cancer types, yet studies specifically exploring their roles in breast cancer remain scarce.

Methods: A comprehensive analysis integrating bulk RNA-seq transcriptomics, methylomics, single-cell transcriptomics, and spatial single-cell transcriptomics data was conducted to elucidate the distinctive characteristics of FPRs in breast cancer. This study particularly focused on delineating the e xpression profiles of FPR3 across distinct breast cancer subtypes, while systematically investigating its prognostic implications and association with macrophage polarization patterns in breast cancer patients. Furthermore, molecular docking analysis was performed to screen potential therapeutic compounds targeting FPR3, providing insights into its druggability.

Results: Notably, FPR3 was found to be highly expressed in macrophages within breast cancer tissues, with a notably elevated level in HER2-positive and triple-negative breast cancer (TNBC) subtypes, both of which are associated with poor prognosis. FPR3 expression inversely correlates with promoter methylation levels. Further analysis of pan-cancer immune infiltration patterns uncovered a striking association between FPR3 and macrophage infiltration, as well as their polarization status. Knockdown of FPR3 expression in macrophages markedly enhanced the expression of IL6, TNF-α, and TGF-β, while significantly reducing IL10 levels, indicative of a shift towards an M1-like macrophage phenotype. Through computational molecular docking analyses, Otamixaban and Rivaroxaban emerged as promising candidate inhibitors of FPR3.

Conclusions: These findings underscore the profound infiltration of FPR3?+?macrophages in breast cancer patients with adverse prognoses, highlighting FPR3 as a potential therapeutic target for intervening breast cancer aggressiveness.

Substances (14)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Rivaroxaban 366789-02-8 C19H18ClN3O5S 1016 suppliers $5.00-$3515.00
Rivaroxaban 366789-02-8 C19H18ClN3O5S 1016 suppliers $5.00-$3515.00
Rivaroxaban 366789-02-8 C19H18ClN3O5S 1016 suppliers $5.00-$3515.00
Rivaroxaban 366789-02-8 C19H18ClN3O5S 1016 suppliers $5.00-$3515.00
PHORBOL 12-MYRISTATE 13-ACETATE 16561-29-8 C36H56O8 420 suppliers $37.00-$2757.40
PHORBOL 12-MYRISTATE 13-ACETATE 16561-29-8 C36H56O8 420 suppliers $37.00-$2757.40
PHORBOL 12-MYRISTATE 13-ACETATE 16561-29-8 C36H56O8 420 suppliers $37.00-$2757.40
PHORBOL 12-MYRISTATE 13-ACETATE 16561-29-8 C36H56O8 420 suppliers $37.00-$2757.40
Rivaroxaban 366789-02-8 - Inquiry
Rivaroxaban 366789-02-8 - Inquiry

Similar articles

IF:6.9

Therapeutic effects of guanidine hydrochloride on breast cancer through targeting KCNG1 gene.

Biomedicine & Pharmacotherapy Mehdi Roshanian Bakhsh, Leila Rouhi,etc Published: 1 August 2023
IF:7.1

Cold atmospheric plasma restores skewed macrophage polarization in triple negative breast cancers via enhancing KAT6A acetylation

Free Radical Biology and Medicine Kaiyuan Zhu, Qing lv,etc Published: 23 November 2024
IF:4.6

Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer.

iScience Xu Yang,?Li Deng,etc Published: 16 October 2023
大英县| 疏勒县| 万山特区| 陆丰市| 福建省| 通道| 保德县| 盘山县| 廉江市| 谷城县| 六安市| 吉木乃县| 股票| 迭部县| 陆丰市| 黔南| 陵水| 临漳县| 湖南省| 五华县| 海阳市| 获嘉县| 楚雄市| 河源市| 沂南县| 蓝田县| 乌苏市| 土默特右旗| 乌什县| 江达县| 楚雄市| 太康县| 明光市| 桂林市| 蕲春县| 车致| 盈江县| 鹿邑县| 黑山县| 谢通门县| 金阳县|